Short Read Sequencing Market Research Report By Application (Clinical diagnostics, Agrigenomics, Oncology, Genomics Research, Molecular Biology), By Technology (Illumina sequencing, Ion Torrent sequencing, SOLiD sequencing, SMRT sequencing), By End Use (Academic research institutes, Pharmaceutical companies, Biotechnology companies, Hospitals and clinics), By Product Type (Sequencing kits, Sequencing services, Sequencing instruments) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 203

Short Read Sequencing Market Overview:

As per MRFR analysis, the Short Read Sequencing Market Size was estimated at 7.07 (USD Billion) in 2023. The Short Read Sequencing Market Industry is expected to grow from 7.71(USD Billion) in 2024 to 20 (USD Billion) by 2035. The Short Read Sequencing Market CAGR (growth rate) is expected to be around 9.05% during the forecast period (2025 - 2035).

Key Short Read Sequencing Market Trends Highlighted

The Global Short Read Sequencing Market is experiencing significant growth driven by advancements in sequencing technologies and increasing demand for genetic research. Key market drivers include the need for rapid, cost-effective methods in genomics that enable researchers to generate high-quality data with increased accuracy. This trend is further supported by the rise in government initiatives aimed at promoting personalized medicine and genomic studies, which are fostering an environment conducive to innovation. Opportunities to be explored in this market include collaborations between technology developers, academic institutions, and healthcare providers, focusing on expanding applications in diagnostics, oncology, and rare disease research.These partnerships can develop advanced tools for data analysis and integration, which will help in sequencing at a greater number of institutions across the world.

Recently, there appears to be a focus on miniaturization and automation in sequencing technologies which increases throughput and efficiency. Furthermore, improvements in bioinformatics are strengthening the capabilities to analyze the complex data sets produced from sequencing, thus increasing the value of short read technologies in research and clinical practices. As these nations invest in genomic technologies, the need for applications in short read sequencing will grow, particularly in areas focusing on genomic medicine.This includes a growing focus on population genomics, which aims to unravel genetic variations and their implications on health. Thus, the Global Short Read Sequencing Market is positioned to expand as more stakeholders recognize the value it brings to medical research and therapeutic developments.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Drivers

Rising Demand for Personalized Medicine

The Global Short Read Sequencing Market Industry is experiencing significant growth driven by the increasing demand for personalized medicine. According to the Global Genomic Medicine Market report, the personalized medicine sector is anticipated to grow at a CAGR of approximately 11.5% from 2023 to 2030. This rise is primarily fueled by advancements in genomic profiling techniques, which allow for tailored therapeutic strategies based on individual genetic makeup.Leading organizations such as the National Institutes of Health (NIH) in the United States, through initiatives like the Precision Medicine Initiative, are heavily investing in genomic research. Their support facilitates innovations in short read sequencing technologies, thus promoting the wider adoption of genomic solutions in clinical settings. The ability to provide customized treatment plans has been shown to lead to better patient outcomes, making it a pivotal factor in the expansion of the Global Short Read Sequencing Market Industry.

Increased Research and Development Activities

Research and Development activities in genetic research and diagnostics have significantly intensified, propelling the growth of the Global Short Read Sequencing Market Industry. In recent years, it has been observed that R investments in biotechnology and genomics rose by approximately 15% globally, according to the Biotechnology Innovation Organization (BIO). Key players like Illumina and Thermo Fisher Scientific are consistently increasing their R budgets to innovate and enhance their sequencing platforms.For instance, Illumina's commitment to advancing its sequencing technology has effectively improved accuracy and reduced costs, fostering a surge in adoption among researchers and clinical laboratories.

Technological Advancements in Sequencing Techniques

The Global Short Read Sequencing Market Industry is significantly influenced by rapid technological advancements in sequencing techniques. The introduction of next-generation sequencing platforms has revolutionized the field, enabling faster and more cost-effective sequencing. A report from the National Human Genome Research Institute indicates that the cost of sequencing a human genome has dropped from approximately $100 million in 2001 to less than $1,000 in recent years.This dramatic price reduction enhances accessibility for researchers globally, accelerating the pace of genomic discoveries. Companies such as BGI Genomics are at the forefront, continually evolving their sequencing technologies to cater to diverse applications from clinical diagnostics to agricultural genomics.

Short Read Sequencing Market Segment Insights:

Short Read Sequencing Market Application Insights

The Global Short Read Sequencing Market is experiencing significant expansion, particularly within the Application segment. In 2024, the Application segment contributed substantially to the market, with clinical diagnostics leading the way, valued at 2.5 USD Billion. Clinical diagnostics is crucial for identifying diseases and personalizing treatment protocols, which continues to drive its importance in the healthcare industry. Following closely is the Agrigenomics segment, valued at 1.6 USD Billion, which plays a significant role in enhancing crop yields and resistance to pests through genetic insights.Oncology application was also paramount, valued at 2.2 USD Billion in 2024, as it enabled precision medicine, allowing for targeted therapies based on genetic markers of tumors, thus addressing the needs of an aging population facing increased cancer prevalence. Genomics Research is included in the Application segment, with a valuation of 0.9 USD Billion, reflecting ongoing advancements in understanding genetic contributions to health and disease, driving discovery in various fields.

Meanwhile, Molecular Biology, valued at 0.51 USD Billion, provides foundational knowledge for all other segments through research on the structure and function of macromolecules essential for life.As the Global Short Read Sequencing Market continues to evolve, the integration of these applications drives innovation and growth, with Clinical diagnostics, Agrigenomics, and Oncology holding majorities in market valuation, highlighting their dominance and importance in real-world applications. These segments are not only revenue-generating but also transformative for healthcare and agriculture globally, paving the way for improved patient outcomes and sustainable food production. The market is expected to yield substantial growth opportunities as technology develops and expands into new applications, solidifying the significance of each area in global health and agricultural advancements.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Technology Insights

The Global Short Read Sequencing Market, particularly within the Technology segment, was poised for significant growth, with a valuation reaching 7.71 USD Billion in 2024 and expected to expand further in the coming years. The market is driven by advancements in genomic research, personalized medicine, and a surge in applications across various healthcare domains. Key technologies like Illumina sequencing play a dominant role due to their high throughput and cost-effectiveness, making them a preferred choice for many researchers. Furthermore, Ion Torrent sequencing is gaining traction, offering rapid results through semiconductor technology, catering to clinical diagnostics and research needs efficiently.

SOLiD sequencing, while less dominant, presents unique applications in targeted resequencing and transcriptome analysis, contributing to niche research areas. SMRT sequencing is also significant, particularly for its capability to produce long reads that enhance genome assembly and structural variant detection, which is crucial for comprehensive genomic studies. Collectively, these technologies underline the dynamic nature of the Global Short Read Sequencing Market industry, reflecting trends toward precision medicine and enhancing the understanding of complex genetic diseases.The market's growth is underpinned by continuous innovation and a robust demand for comprehensive sequencing data across global healthcare sectors.

Short Read Sequencing Market End Use Insights

The Global Short Read Sequencing Market exhibits notable segmentation based on End Use, encompassing various sectors such as Academic research institutes, Pharmaceutical companies, Biotechnology companies, and Hospitals and clinics. In 2024, the overall market reached a valuation of 7.71 USD Billion, with significant contributions from these sectors. Academic research institutes play a crucial role, often driving innovation and advancements in genomics, thereby utilizing Short Read Sequencing technology for various biological studies.Pharmaceutical companies benefit significantly from this technology by enhancing drug discovery processes and personalized medicine approaches, facilitating faster and more accurate genomic analysis.

Similarly, Biotechnology companies are vital, as they leverage Short Read Sequencing for the development of new therapies and diagnostics, enhancing their operational efficiencies. Hospitals and clinics increasingly adopt this technology to improve patient outcomes through better diagnoses and treatment plans. This diverse End Use landscape not only demonstrates the importance of Short Read Sequencing in advancing biological and medical science but also highlights the growing market demand, maintaining significant growth opportunities in the Global Short Read Sequencing Market industry.

Short Read Sequencing Market Product Type Insights

The Global Short Read Sequencing Market is experiencing robust growth driven by technological advancements and increasing demand for genomic research. In 2024, the overall market was valued at 7.71 billion USD, showcasing a strong upward trajectory. Within this market, Product Type include sequencing kits, sequencing services, and sequencing instruments. Sequencing kits play a pivotal role as they provide essential tools for researchers and laboratories, facilitating efficient sample processing and data acquisition. Sequencing services have also evolved significantly, offering tailored solutions that cater to diverse customer needs, from small-scale projects to large genomic studies.

Furthermore, sequencing instruments are critical as they support high-throughput capabilities, increasing the overall productivity of genomic workflows. As the Global Short Read Sequencing Market continues to grow, with projections reaching 20.0 billion USD by 2035, the overall market statistics reflect the increasing reliance on genomic data across various sectors, including healthcare and personalized medicine. The significant growth drivers include advancements in technology, increased funding for genetic research, and raising awareness of genomics' potential benefits, while challenges may arise from high costs and data management complexities.Overall, these insights underline the importance of each product type in driving the market forward.

Short Read Sequencing Market Regional Insights

The Global Short Read Sequencing Market is projected to experience significant growth across various regional segments, with North America leading the charge in market revenue. In 2024, North America was valued at 3.6 USD Billion and is expected to grow to 9.5 USD Billion by 2035, making it a key player in driving advancements in the field. Europe followed, with a valuation of 2.0 USD Billion in 2024 and an anticipated 5.2 USD Billion by 2035, reflecting its strong emphasis on Research and Development in genomics.

The Asia-Pacific region (APAC), valued at 1.8 USD Billion in 2024, is poised for growth as countries increasingly adopt genomic technologies for clinical applications, reaching 4.7 USD Billion by 2035.South America and the Middle East and Africa (MEA) were smaller markets, with valuations of 0.7 USD Billion and 0.61 USD Billion, respectively in 2024, but both regions show potential for expansion in healthcare initiatives focused on genomics. The varying market dynamics across these regions highlight the importance of localized approaches in harnessing the benefits of the Global Short Read Sequencing Market, ensuring that innovations align with regional healthcare needs and resources.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Key Players and Competitive Insights:

The Global Short Read Sequencing Market is experiencing significant evolution as advancements in sequencing technologies continue to reshape the landscape of genomics. Competitive insights into this market reveal a dynamic environment characterized by rapid innovation, diverse product offerings, and an increasing number of players. The growing demand for high-throughput sequencing solutions in various applications, including personalized medicine, genomics research, and agricultural applications, is pushing companies to enhance their development initiatives. This competitive atmosphere is also fueled by strategic collaborations, partnerships, and mergers aimed at expanding capabilities while ensuring access to cutting-edge technologies. In addition, market dynamics are influenced by investments in research and development, geographic expansion, and a focus on improving customer service and product quality, which are crucial for maintaining a competitive edge.

Novogene stands out in the Global Short Read Sequencing Market due to its robust technological capabilities and comprehensive service offerings. With a strong focus on high-throughput sequencing technologies, Novogene has established itself as a key player, offering a wide range of sequencing services tailored for academic and pharmaceutical clients. The company’s strengths lie in its ability to deliver high-quality genomic data with a quick turnaround time, supported by its state-of-the-art facilities and advanced bioinformatics solutions. This positions Novogene as a preferred choice for organizations seeking reliable sequencing services. Additionally, Novogene's commitment to expanding its global presence through strategic partnerships and collaborations further enhances its position, making it well-equipped to cater to an ever-growing customer base in the short read sequencing landscape.

Thermo Fisher Scientific plays a formidable role in the Global Short Read Sequencing Market, leveraging its extensive portfolio of key products and services that support genomic research. With an emphasis on delivering innovative solutions,Thermo Fisher provides a variety of next-generation sequencing platforms, reagents, and bioinformatics tools that cater to diverse customer needs globally. The company’s strengths are highlighted through its significant investment in research and development, enabling continuous innovation and enhancement of its sequencing systems. Moreover, Thermo Fisher has bolstered its market presence through strategic mergers and acquisitions, allowing for an integration of complementary technologies that expand its capabilities in the genomics space. Through these initiatives, Thermo Fisher Scientific remains at the forefront of advancing short read sequencing technologies while addressing the requirements of researchers and clinicians worldwide.

Key Companies in the Short Read Sequencing Market Include:

• Novogene


• Thermo Fisher Scientific


• Pacific Biosciences


• Roche


• Zymo Research


• Genomatix


• Illumina


• 10x Genomics


• Sangamo Therapeutics


• Agilent Technologies


• BGI


• Eurofins Genomics


• Qiagen


• Oxford Nanopore Technologies

Short Read Sequencing Market Industry Developments

The Global Short Read Sequencing Market has recently experienced notable developments, including advancements in technology and increased investments in genomics research. Companies like Illumina and Thermo Fisher Scientific have expanded their product offerings to enhance sequencing platforms and improve accuracy. Novogene has launched innovative solutions that cater to large-scale sequencing projects, responding to the rising demand for genomic data in healthcare and research.In terms of mergers and acquisitions, it was reported that Thermo Fisher Scientific acquired Bectin Dickinson's biosciences business in July 2022, bolstering its portfolio in molecular biology and diagnostics. Additionally, Pacific Biosciences announced its acquisition of Omniome in September 2021, enhancing its sequencing capabilities.The market valuation has been positively impacted by increased funding in genetic research, particularly from government entities focusing on personalized medicine. As of October 2023, the demand for high-throughput sequencing technologies has accelerated, reflecting their essential role in infectious disease research and oncology. Over the past two years, collaborations between companies and academic institutions have also intensified, highlighting the shift towards precision medicine as a central theme in the Global Short Read Sequencing Market.

Short Read Sequencing Market Segmentation Insights

Short Read Sequencing Market Application Outlook

• Clinical diagnostics


• Agrigenomics


• Oncology


• Genomics Research


• Molecular Biology

Short Read Sequencing Market Technology Outlook

• Illumina sequencing


• Ion Torrent sequencing


• SOLiD sequencing


• SMRT sequencing

Short Read Sequencing Market End Use Outlook

• Academic research institutes


• Pharmaceutical companies


• Biotechnology companies


• Hospitals and clinics

Short Read Sequencing Market Product Type Outlook

• Sequencing kits


• Sequencing services


• Sequencing instruments

Short Read Sequencing Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa


•  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	7.07(USD Billion)
MARKET SIZE 2024	7.71(USD Billion)
MARKET SIZE 2035	20.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.05% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Novogene, Thermo Fisher Scientific, Pacific Biosciences, Roche, Zymo Research, Genomatix, Illumina, 10x Genomics, Sangamo Therapeutics, Agilent Technologies, BGI, Eurofins Genomics, Qiagen, Oxford Nanopore Technologies
SEGMENTS COVERED	Application, Technology, End Use, Product Type, Regional
KEY MARKET OPPORTUNITIES	Increased demand for genomic research, Advancements in sequencing technologies, Rise in personalized medicine, Growth of oncology-related applications, Expansion in academic and research institutions.
KEY MARKET DYNAMICS	growth in genomics research, increasing adoption of NGS technologies, advancements in bioinformatics tools, rising demand for personalized medicine, declining sequencing costs
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA